Lapse-supported life insurance and adverse selection

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000cab a2200000   4500</leader>
    <controlfield tag="001">MAP20260012186</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20260422174744.0</controlfield>
    <controlfield tag="008">260421e20260413che|||p      |0|||b|eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
      <subfield code="d">MAP</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">6</subfield>
    </datafield>
    <datafield tag="100" ind1=" " ind2=" ">
      <subfield code="0">MAPA20260007243</subfield>
      <subfield code="a">Haçariz, Oytun</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="0">
      <subfield code="a">Lapse-supported life insurance and adverse selection</subfield>
      <subfield code="c">Oytun Haçariz, Torsten Kleinow and Angus S. Macdonald</subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">The article analyzes how life insurance policies with lapse-supported premiums amplify the costs of adverse selection. Using Term to 100 contracts as a case study, the authors examine the impact of differences in mortality and lapse behavior, particularly under restrictions on medical underwriting such as bans on the use of genetic testing. Three strategies for managing lapse surplus are compared: elimination by design, retrospective distribution, and prospective distribution. The results show that lapse-supported premiums significantly increase exposure to adverse selection, especially when a secondary market exists and lapse behavior is differential. The study concludes that different modeling approaches produce robust and comparable results</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080570590</subfield>
      <subfield code="a">Seguro de vida</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080542160</subfield>
      <subfield code="a">Primas</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080582661</subfield>
      <subfield code="a">Selección adversa</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080604998</subfield>
      <subfield code="a">Cancelación de pólizas</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080554330</subfield>
      <subfield code="a">Excedentes</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080564322</subfield>
      <subfield code="a">Tarificación</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080592011</subfield>
      <subfield code="a">Modelos actuariales</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20260007250</subfield>
      <subfield code="a">Kleinow, Torsten</subfield>
    </datafield>
    <datafield tag="700" ind1=" " ind2=" ">
      <subfield code="0">MAPA20110007911</subfield>
      <subfield code="a">MacDonald, Angus S.</subfield>
    </datafield>
    <datafield tag="710" ind1="2" ind2=" ">
      <subfield code="0">MAPA20180008764</subfield>
      <subfield code="a">Springer</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="w">MAP20220007085</subfield>
      <subfield code="g">13/04/2026 Número 16 issue 1 - abril 2026 , 33 p.</subfield>
      <subfield code="t">European Actuarial Journal</subfield>
      <subfield code="d">Cham, Switzerland  : Springer Nature Switzerland AG,  2021-2022</subfield>
    </datafield>
  </record>
</collection>